Financials
Value Q1, 25Q2, 25Q3, 25Q4, 25Q1, 26 TTM Selling/general/admin expenses 2.16 M265.39 K844.34 K996.2 K477.57 K 2.58 M Research & development 364 K476 K39.68 K-17.69 K666.4 K 1.16 M Operating income -2.21 M-2.76 M-8.57 M1.08 M-1.13 M -11.38 M Non-Operating Income, Total 42 K15.43 K-20.99 K75.39 K144.42 K 214.25 K Interest expense, net of interest capitalized —56.14 K25.6 K9 9440 91.69 K Non-Operating Income, excl. Interest Expenses -12 K-44.57 K-25.6 K45.01 K-2 845 -28.01 K Unusual income/expense 54 K60 K4 61430.39 K147.26 K 242.27 K Pretax income 1.48 M-2.62 M-8.62 M3.16 M-988.37 K -9.08 M Equity in earnings ————— — Taxes 7 0008 000-14 K—— — Non-controlling/minority interest ——-161.49 K-54.22 K-22.61 K — After tax other income/expense 9 0005 000—00 — Net income before discontinued operations 1.47 M-2.63 M-8.43 M1.1 M-962.91 K -10.93 M Discontinued operations ————— — Net income 1.47 M-2.63 M-8.43 M1.1 M-962.91 K -10.93 M Dilution adjustment ————— — Preferred dividends ————— — Diluted net income available to common stockholders 1.47 M-2.63 M-8.43 M-672.2 K-962.91 K -12.7 M Basic earnings per share (Basic EPS) 18.98-2.25-3.12762.1-0.15 756.58 Diluted earnings per share (Diluted EPS) 18.98-2.25-3.12762.1-0.15 756.58 Average basic shares outstanding 77.67 K1.17 M2.76 M2.16 M6.69 M — Diluted shares outstanding 77.67 K1.17 M2.76 M2.16 M6.69 M — EBITDA -2.2 M-2.76 M——— — EBIT -2.21 M-3.95 M-8.57 M5.2 M-1.13 M -8.46 M Cost of revenue 432 K643 K16.58 K-990.63 K14.95 K -316.11 K Other cost of goods sold ————— — Depreciation & amortization (cash flow) 4 0004 000——— —